drugset / Trial / NCT07060885
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
Phase 3
Active not recruiting
327 enrolled
ALK-Abelló A/S
Changchun GeneScience Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A research study of house dust mite (HDM) SLIT-tablet for the treatment of HDM allergy in Chinese participants aged 12-65.
Timeline
- Start
- 2025-09-01
- Primary completion
- 2026-09-06
- Completion
- 2026-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acarizax | Unknown | 12 unknown | — |